Figure 2.
A 2-log drop in BCR-ABL mRNA at the time of CCR predicts better progression-free survival. The cumulative rate of progression-free survival (Kaplan-Meier method) is shown for those subjects achieving, versus not achieving, a minimal 2.0 log-drop in BCR-ABL mRNA at the time of first CCR.